BCI startup Neurable looks to license its ‘mind-reading’ tech for consumer wearables

The startup specializes in "non-invasive" "mind-reading" tech—a kind of neural data collection that, its CEO hopes, will have ...
PharmiWeb

Neurable Open for Business: Scaling Neurotechnology Adoption Through Global OEM Integration

New leadership and OEM momentum position the company for its next phase of commercialization at scaleBOSTON--(BUSINESS WIRE)--Neurable, the leader in AI for noninvasive brain-computer interface (BCI) ...

VisionSys AI Inc. Announces Proposed $90 Million Strategic Investment at $1.50 Per Share

VisionSys AI Inc. (NASDAQ: VSA) (“VSA” or the “Company”) today announced that it is in advanced discussions with a strategic investor regarding a proposed strategic investment. Based on the terms ...

Get Ready for More Brain-Scanning Consumer Gadgets

Neurable, which makes noninvasive brain-computer interfaces, is licensing its technology and promises a “flood” of new third-party hardware this year and next.
Hosted on MSN

FDA clears first trial of implant for treatment-resistant depression

The FDA has authorized Motif Neurotech to begin clinical testing of its brain implant aimed at adults with treatment-resistant depression. The RESONATE study will assess safety, symptom improvement, ...